DOI:
10.1055/s-00050098
Journal of Coloproctology
LinksClose Window
References
Fonsatti E, Altomonte M, Arslan P, Maio M.
Endoglin (CD105): a target for anti-angiogenetic cancer therapy.
Curr Drug Targets 2003;
4 (04) 291-296
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.